How does a breakthrough gene therapy begin? What does it take to turn a scientific idea into a treatment that can reach a patient?
In this interview, Duško Lainšček, researcher at the Institute of Chemistry of Slovenia and member of the Centre for the Technologies of Gene and Cell Therapy (CTGCT), shares his journey from veterinary medicine to the forefront of genome editing and gene therapy development. He discusses the promise of CRISPR-based technologies, the challenges of translating research into clinical applications, and the remarkable story behind the development of a pioneering therapy for CTNNB1 syndrome.
Through examples from his own work, Duško Lainšček explains how scientific research can translate into real-world impact for patients and families facing rare genetic diseases.
Read the full interview to learn more about the science, the challenges, and the people driving innovation in gene and cell therapy. The interview is in Slovene, so we suggest using the automatic browser translations if you are not fluent in Slovene.